View allAll Photos Tagged MedTech
On Monday, 10 February, ESCP Business School’s London Campus and the Blue Factory hosted its first external startup launch event for Adexa Labz, an AI and MedTech startup.
The event brought together industry leaders, students, entrepreneurs, and investors to celebrate the launch of Adexa Labz, which, after two years of refining its research and business strategy, is now preparing to embark on its fundraising journey.
A startup launch event is a unique opportunity for founders to showcase their vision, mission, and innovative solutions to their target audience. For attendees, it offers a chance to gain new insights, participate in relevant discussions, and become part of the story of a new venture.
The MedTech sector is growing because of demographic shifts, technological innovations, and the expansion of non-traditional care settings. Adexa Labz aims to tackle critical challenges in patient care, diagnostics, and medical efficiency by integrating cutting-edge AI with a strong focus on MedTech solutions.
Read more: escp.eu/news/escp-blue-factory-hosts-medtech-startup-laun...
Conor Hale
Senior Editor, Fierce Medtech
Kelvin Baggett
Managing Director, Head of Patient Impact and Chair of the EMPIRIC Institute, Patient Square Capital
Andrew Fish
President and CEO, Medical Device Innovation Consortium
Nada Hanafi
Founder and Manager, MedTech Strategy Advisors, LLC; Founder, MedTech Color
Ryan Lakin
Divisional Vice President for Medical Devices and Digital Solutions, Abbott
Michelle Tarver
Deputy Center Director, Chief Transformation Officer, Center for Devices and Radiological Health, US Food and Drug Administration
Watch the session: milkeninstitute.org/events/global-conference-2024/program
Conor Hale
Senior Editor, Fierce Medtech
Theresa LaVallee
Chief Development Officer, Coherus BioSciences
Joni Rutter
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Laurence Sperling
Chief Medical Officer, Family Heart Foundation
Peter Stein
Director, Office of New Drugs, US Food and Drug Administration